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Tobacco use in pregnancy: a window of opportunity 
for prevention
Tobacco use is poised to kill as many as 1 billion people 
in the 21st century, primarily from non-communicable 
diseases.1 Less often noted is the eﬀ ect of tobacco use 
and second-hand smoke exposure on maternal and 
child health. Cigarette smoking during pregnancy poses 
serious risk to the mother and her developing child, 
and second-hand smoke exposure is now recognised 
as an important cause of adult and child morbidity 
and mortality.2,3 Pregnancy is an ideal opportunity to 
intervene with mothers and families to prevent and 
control tobacco use, and should be a priority for both 
tobacco control and maternal and child health experts.  
Understanding the scope of maternal tobacco use and 
mothers’ and children’s second-hand smoke exposure 
to intervene and address these problems requires up-
to-date, nationally representative, comparable data. 
However, surveillance deﬁ cits are common, even in 
high-income countries in which women’s tobacco use 
has been a problem for decades.4 Deﬁ cits in data are far 
more pronounced in low-income and middle-income 
countries (LMICs), especially those in which tobacco 
control eﬀ orts are not yet robust.  
In The Lancet Global Health, Rishi Caleyachetty and 
colleagues5 provide the most comprehensive assessment 
of tobacco use in pregnant women in LMICs so far. The 
authors used data from the nationally representative 
household Demographic and Health Surveys (DHS) 
that provide data for many topics, including tobacco 
use in pregnancy. In 54 countries where the DHS 
was conducted between 2001 and 2012, the overall 
prevalence of any form of tobacco use in pregnant 
women was 2·6% (1·3% smoking; 0·9% smokeless 
tobacco). Tobacco use during pregnancy was reported in 
all WHO regions, and some countries had much higher 
maternal smoking rates, such as Nepal (5·9%), Jordan 
(9·6%), and Turkey (15·0%). In 21 countries, maternal 
smokeless tobacco use was higher than was tobacco 
smoking, emphasizing the importance of assessing all 
forms of tobacco use.  
Although these ﬁ ndings provide a crucial baseline, 
substantial research needs remain. For example, we 
know comparatively little about patterns of tobacco 
use in pregnancy, especially for products other than 
manufactured cigarettes. We also know little about 
factors that contribute to tobacco use during pregnancy, 
which are likely to vary within and between countries 
and geographic regions. Finally, data for second-hand 
smoke exposure are insuﬃ  cient. Household second-
hand smoke exposure is likely to be substantial in 
countries with high male smoking rates; in women and 
children, the disease burden from second-hand smoke 
exposure could well equal or exceed that from direct 
smoking in many LMICs.  
One of the bright spots in global tobacco control 
eﬀ orts has been the relatively low prevalence of 
tobacco use in women, particularly in LMICs. In 2011, 
for example, the estimated overall global prevalence of 
tobacco smoking among women (aged ≥15 years) was 
8% compared with 36% for men.6 The importance of 
averting a rise in prevalence of tobacco use in women—
and not taking lower rates of use for granted—has long 
been recognised.7 A key challenge will be to constrain 
the growth in women’s tobacco use, as cultural 
and economic barriers fall in the face of economic 
globalisation, modernisation, and crucially needed 
improvements in the status of women.8   
Concrete eﬀ orts are underway to address 
tobacco use in pregnancy. In 2013, WHO published 
recommendations for the prevention and management 
of tobacco use and second-hand smoke exposure in 
pregnancy, noting that pregnancy is often a window 
of opportunity to intervene with women and their 
families.9 The document provides evidence-based 
guidelines applicable to all countries, and urges health 
centres, hospitals, and clinics to practise what their 
providers preach through access to tobacco-free health-
care facilities and having health-care providers as 
tobacco-free role models. Regrettably, rates of tobacco 
use in health professionals remain high in many 
countries, and tobacco-free health-care facilities are not 
yet the global norm.
Much remains to be done. In the 20th century, 
the tobacco industry succeeded in ‘‘engineering the 
consent’’ of women in high-income countries to 
embrace tobacco use, resulting in millions of premature 
deaths.10 Similar tactics are now being deployed towards 
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women in many LMICs, because, as Caleyachetty and 
colleagues rightly observe, as long as tobacco use 
remains much lower in women than men, women will 
constitute an obvious target for multinational tobacco 
companies. Despite progress, many challenges remain 
to improve global maternal and child health. Increased 
tobacco use by pregnant women will worsen pregnancy 
outcomes, especially in resource-poor settings, and 
threatens to undermine or reverse hard-won gains in 
maternal and child health. Conversely, taking advantage 
of a vital window of opportunity to intervene can 
prevent an even greater burden of tobacco-caused 
disease and provide lasting beneﬁ ts for women and 
their families.  
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